1 / 4

The Effective Date Of Glucometer, Nebulizer, BP Monitoring Devices, Digital Thermometer To Be Considered As Drugs Extend

Extending the deadline for re-classification of these devices as drugs will prevent putting up unnecessary burden on manufacturers and authorities regarding the drug license registration process

akashmishra15
Download Presentation

The Effective Date Of Glucometer, Nebulizer, BP Monitoring Devices, Digital Thermometer To Be Considered As Drugs Extend

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Effective Date Of Glucometer, Nebulizer, BP Monitoring Devices, Digital Thermometer To Be Considered As Drugs Extended Summary: Extending the deadline for re-classification of these devices as drugs will prevent putting up unnecessary burden on manufacturers and authorities regarding the drug license registration process. In pursuance sub-clause (iv) of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the government recently amended a previous notification from the Ministry of Health & Family Welfare. The amendment is concerned with the extension of timeline of several medical devices as ‘drugs’. Where the effective date of implementation has been extended for a period of one year, and will come into effect from 1st of January, 2021. Contact No: +91 7672005050 Email: contact@cliniexperts.com

  2. The devices being considered for extension of timeline under this notification include: ●Glucometer ●Nebulizer ●BP Monitoring Devices ●Digital Thermometer The principal notification was published in the Gazette of India Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 5980(E), dated the 3rd December, 2018. Why was this step taken by the government The medical device market in India is not very strictly regulated. As medical devices are guarded by more lenient regulations for clinical trials and approval (especially Class I and Class II devices), the market has become crowded by substandard products. Not to Contact No: +91 7672005050 Email: contact@cliniexperts.com

  3. mention the level of duplicacy which is quite profound at certain levels. At the moment, only 23 medical devices have been classified as drugs in India. But with the growing scope and need of medical devices in the ever expanding Indian health sector. More and more devices shall be brought under this category to improve citizen safety. The government’s goal is to ensure that the quality of medical devices being sold in the Indian market shall be proper and soundly regulated by rules and regulations. Contact No: +91 7672005050 Email: contact@cliniexperts.com

  4. Medical devices now being classified as drugs will have to be mandatorily registered by CDSCO and provide detailed information about its manufacture and use. Moreover, bringing devices under the category of drugs will allow the authorities to properly regulate their price and quality standards. What does the industry think? Stakeholders in the medical device manufacturing and marketing sector are viewing this new regulation as a positive step. Since regulating more medical devices will help enhance their quality and the credibility of the manufacturing company. However, the stakeholders are demanding for a separate act specially formulated for medical devices, since the regulation procedure for drugs is quite stringent at the moment. Contact No: +91 7672005050 Email: contact@cliniexperts.com

More Related